Fosinopril



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 83.3%
Product Used For Unknown Indication 8.3%
Coronary Artery Disease 4.2%
Prophylaxis 4.2%
Angioedema 26.9%
Lip Oedema 7.7%
Mental Impairment 7.7%
Renal Failure 7.7%
Dysarthria 3.8%
Head Discomfort 3.8%
Memory Impairment 3.8%
Pain 3.8%
Pancreatitis 3.8%
Peripheral Coldness 3.8%
Pharyngeal Oedema 3.8%
Pruritus 3.8%
Renal Failure Acute 3.8%
Swelling Face 3.8%
Treatment Noncompliance 3.8%
Vomiting 3.8%
Weight Increased 3.8%
Secondary
Hypertension 44.3%
Product Used For Unknown Indication 15.7%
Drug Use For Unknown Indication 12.9%
Coronary Artery Disease 5.7%
Depression 5.7%
Blood Pressure High 4.3%
Acid Reflux (Esophageal) 1.4%
Arthritic Pains 1.4%
Arthritis 1.4%
Benign Prostatic Hyperplasia 1.4%
Crohn's Disease 1.4%
Diabetes Mellitus 1.4%
Gastrooesophageal Reflux Disease 1.4%
Hyperthyroidism 1.4%
Renal Failure 29.4%
Sick Sinus Syndrome 11.8%
Weight Decreased 11.8%
Agranulocytosis 5.9%
Allergic Myocarditis 5.9%
Angioneurotic Oedema 5.9%
Completed Suicide 5.9%
Heart Transplant 5.9%
Nausea 5.9%
Orthostatic Hypotension 5.9%
Rash Pruritic 5.9%
Concomitant
Product Used For Unknown Indication 24.2%
Hypertension 15.7%
Drug Use For Unknown Indication 7.2%
Diabetes Mellitus 6.3%
Cardiac Failure Congestive 4.8%
Blood Cholesterol Increased 4.3%
Hormone Replacement Therapy 4.3%
Depression 3.8%
Rheumatoid Arthritis 3.4%
Diffuse Large B-cell Lymphoma 3.1%
Type 2 Diabetes Mellitus 2.9%
Blood Pressure 2.6%
Chronic Obstructive Pulmonary Disease 2.6%
Gastrooesophageal Reflux Disease 2.4%
Squamous Cell Carcinoma Of Head And Neck 2.4%
Cardiac Disorder 2.2%
Psoriasis 2.2%
Pain 2.0%
Anxiety 1.9%
Blood Cholesterol 1.9%
Renal Failure 10.5%
Vomiting 9.3%
Breast Cancer Female 7.0%
Upper Gastrointestinal Haemorrhage 7.0%
Visual Impairment 7.0%
Rash 5.8%
Drug Ineffective 4.7%
International Normalised Ratio Increased 4.7%
Myocardial Infarction 4.7%
Thrombocytopenia 4.7%
Cardiac Failure Congestive 3.5%
Injection Site Pain 3.5%
Myalgia 3.5%
Nausea 3.5%
Squamous Cell Carcinoma 3.5%
Subdural Haematoma 3.5%
Syncope 3.5%
Weight Decreased 3.5%
Weight Increased 3.5%
Wheezing 3.5%